Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes

Emmanuelle Le Page; Gilles Edan

doi:10.1177/1352458517695893

Journal articles

Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes

Emmanuelle Le Page ^{1, 2, *} Gilles Edan ^{3, 2, 1}

* Corresponding author

1 CIC - Centre d'Investigation Clinique [Rennes]

2 Service de Neurologie [Rennes] = Neurology [Rennes]

3 VisAGeS - Vision, Action et Gestion d'informations en Santé

INSERM - Institut National de la Santé et de la Recherche Médicale : U1228, Inria Rennes – Bretagne Atlantique , IRISA-D5 - SIGNAUX ET IMAGES NUMÉRIQUES, ROBOTIQUE

Abstract : The therapeutic arsenal for preventing multiple sclerosis (MS) relapses strongly improved over the last 20 years with more than 10 disease-modifying drugs now available. However, relapses can still occur, requiring treatment with corticosteroids to accelerate recovery...

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01559941
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Tuesday, July 11, 2017 - 9:56:15 AM
Last modification on : Friday, January 21, 2022 - 3:11:02 AM

Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes

Links full text

Identifiers

Collections

Citation

Export

Metrics

Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics